These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36890432)

  • 1. Cardiovascular risk reduction with integrated care: results of 8 years follow up.
    Smits GHJM; van Doorn S; Bots ML; Hollander M
    BMC Prim Care; 2023 Mar; 24(1):66. PubMed ID: 36890432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the ZWOT-CASE study: an observational study on the effectiveness of an integrated programme for cardiovascular risk management compared to usual care in general practice.
    Marchal S; Hollander M; Schoenmakers M; Schouwink M; Timmer JR; Bilo HJG; Schwantje O; van 't Hof AWJ; Hoes AW
    BMC Fam Pract; 2019 Nov; 20(1):149. PubMed ID: 31675925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
    Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
    JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an observational study in general practice.
    Marchal S; van 't Hof AW; Bilo HJ; Deijns SJ; Heeg JE; Schoenmakers M; Schouwink M; Schwantje O; Bots ML; Hoes AW; Hollander M
    BJGP Open; 2021 Apr; 5(2):. PubMed ID: 33436457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurses' observational study on the practice of secondary prevention in a cardiovascular department.
    Steffenino G; Galliasso M; Gastaldi C; Ricca N; Mangiacotti B
    Ital Heart J; 2003 Jul; 4(7):473-8. PubMed ID: 14558299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Peterson GG; Pu J; Magid DJ; Barterian L; Kranker K; Barna M; Conwell L; Rose A; Blue L; Markovitz A; McCall N; Markovich P
    JAMA Cardiol; 2021 Sep; 6(9):1050-1059. PubMed ID: 34076665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
    Santschi V; Chiolero A; Burnand B; Colosimo AL; Paradis G
    Arch Intern Med; 2011 Sep; 171(16):1441-53. PubMed ID: 21911628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence, biological and lifestyle risk factors in patients with myocardial infarction: a ten-year follow-up on socially differentiated cardiac rehabilitation.
    Hald K; Larsen FB; Nielsen KM; Meillier LK; Johansen MB; Larsen ML; Christensen B; Nielsen CV
    Scand J Prim Health Care; 2019 Jun; 37(2):182-190. PubMed ID: 31122102
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of an integrated care training program for primary care nurses for the secondary prevention of cardiovascular risk.
    Lizcano Álvarez Á; Villar Espejo T; López Köllmer L; Gómez Menor C; Ledesma Rodríguez R; Fernández Zarataín G
    Enferm Clin (Engl Ed); 2021; 31(5):303-312. PubMed ID: 34565502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
    Palmer MJ; Barnard S; Perel P; Free C
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care.
    Rachamin Y; Grischott T; Rosemann T; Meyer MR
    Atherosclerosis; 2021 May; 324():141-147. PubMed ID: 33810858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
    Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
    Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes outcomes in specialist and general practitioner settings in Singapore: challenges of right-siting.
    Wee SL; Tan CG; Ng HS; Su S; Tai VU; Flores JV; Khoo DH
    Ann Acad Med Singap; 2008 Nov; 37(11):929-35. PubMed ID: 19082199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons Learned From a Patient-Centered, Team-Based Intervention for Patients With Type 2 Diabetes at High Cardiovascular Risk: Year 1 Results From the CINEMA Program.
    Neeland IJ; Al-Kindi SG; Tashtish N; Eaton E; Friswold J; Rahmani S; White-Solaru KT; Rashid I; Berg D; Rana M; Sullivan C; Hatipoglu B; Pronovost P; Rajagopalan S
    J Am Heart Assoc; 2022 Aug; 11(15):e024482. PubMed ID: 35904203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega 6 fatty acids for the primary prevention of cardiovascular disease.
    Al-Khudairy L; Hartley L; Clar C; Flowers N; Hooper L; Rees K
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011094. PubMed ID: 26571451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial.
    Östbring MJ; Eriksson T; Petersson G; Hellström L
    BMC Cardiovasc Disord; 2021 Aug; 21(1):367. PubMed ID: 34334142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.